Patient and family experience with chronic transfusion therapy for sickle cell disease: A qualitative study.

Autor: Hawkins LM; Emory University School of Medicine, Atlanta, GA, USA., Sinha CB; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA., Ross D; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA., Yee MEM; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, GA, USA., Quarmyne MO; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, GA, USA., Krishnamurti L; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA.; Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, GA, USA., Bakshi N; Division of Pediatric Hematology-Oncology-BMT, Emory University School of Medicine, Atlanta, GA, USA. nitya.bakshi@emory.edu.; Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, GA, USA. nitya.bakshi@emory.edu.
Jazyk: angličtina
Zdroj: BMC pediatrics [BMC Pediatr] 2020 Apr 18; Vol. 20 (1), pp. 172. Date of Electronic Publication: 2020 Apr 18.
DOI: 10.1186/s12887-020-02078-w
Abstrakt: Background: There is a limited understanding of the patient and family experience of Chronic Transfusion Therapy (CTT) for prevention of complications of Sickle Cell Disease (SCD). We sought to understand patient and family experience with CTT using qualitative methods.
Methods: Fifteen parents of children < 18 years old and nine children 12-18 years old with SCD who were receiving CTT for > 1 year were interviewed using a semi-structured interview format, and interviews were analyzed using open coding methods.
Results: Four themes created a narrative of the patient and family experience of CTT: 1) Burden of CTT, 2) Coping with CTT, 3) Perceived benefits and risks of CTT, and 4) Decision making regarding CTT. Participants reported substantial burden of CTT, including the impact of CTT on daily life and family, distress about venous access, burden of chelation therapy, and anxiety about CTT complications. Participants described how they coped with CTT. Participants reported increased energy, decreased pain, fewer hospitalizations, and stroke prevention with CTT, but also recognized complications of CTT, though awareness was limited in adolescents. Parents described sharing in the informed decision-making process with their healthcare provider about CTT, but adolescent patient participants reported that they were not involved in this process.
Conclusions: CTT is associated with significant patient and family burden. Support from family, healthcare providers and school may help individuals cope with some of this burden. These findings provide the basis for future studies to identify strategies to mitigate the burden of CTT and improve the patient experience with this therapy. Future studies should also systematically assess patient knowledge about the key components of CTT and chelation using quantitative assessments.
Databáze: MEDLINE
Externí odkaz: